HEXO Corp

HEXO Corp. engages in the provision of cannabis and cannabis products. The company was founded by Sébastien St. Louis and Adam Miron on October 29, 2013 and is headquartered in Gatineau, Canada.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Hydropothecary is a licensed producer of medical marijuana under Health Canada’s Access to Cannabis for Medical Purposes Regulations.Their leadership team brings proven scientific, financial, regulatory and entrepreneurial expertise to the rapidly evolving Canadian medical marijuana industry.Hydropothecary is an award-winning medical cannabis producer located on a 143-acre farm in Gatineau, Quebec, in the National Capital Region. Their focus is on product innovation, advanced natural growing techniques, client health and safety, and exceptional customer service. They take their commitment to customers seriously, offering exceptional packaging, courier delivery in Canada (Saturdays where available) and their bilingual, 24-hour customer service.

OTTAWA, June  17, 2020  (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced that it has established an at-the-market equity program (the “ATM Program”) that allows the Company to issue up to C$34,500,000 (or its U.S. dollar equivalent) of common shares (the “Common Shares”) from treasury to the public from time to time, at the Company’s discretion. Any Common Shares sold through the ATM Program will be sold through the Toronto Stock Exchange (the “TSX”), the New York Stock Exchange (the “NYSE”) or any other marketplace on which the Common Shares are listed, quoted or otherwise traded, at the prevailing market price at the time of sale.

HEXO Corp. Announces C$34,500,000 At-the-Market Offering Program

As of June 22, Hexo (NYSE: HEXO) (TSE: HEXO) will no longer be listed on the S&P/TSX composite index.

As Cannabis Stocks Dip, Hexo Is Among The Worst, Cannabis ETF Manager Says

HEXO: Upside Remains After 48% Surge

Aurora Cannabis

Tilray Brands

These three pot stocks are soaring -- unfortunately their rallies lack substance.

Despite Doubling, These Cannabis Stocks Are Bad News

There are good marijuana stocks out there, but these Canadian cannabis companies have serious red flags.

3 Pot Stocks to Stay Miles Away From

Adobe

Snap

SPDR Dow Jones Industrial Average ETF

The Dow Jones Industrial Average, Adobe, Hexo and Snap were our top stock trades after a brutal trading day. So, let's look at the charts.

4 Top Stock Trades for Friday: DIA, SNAP, ADBE, HEXO

Hexo (HEXO) CEO, Sebastien St-Louis on Q3 2020 Results - Earnings Call Transcript

After it received an NYSE listing warning, what is this pot stock doing to recover?

Can HEXO Save Itself From Collapsing?

The Canadian cannabis company's value brand enjoyed especially strong demand.

HEXO Reports Better-Than-Expected Fiscal Q3 Revenue

Investors liked the Canadian cannabis producer's Q3 update.

Why HEXO Shares Are Jumping Today

HEXO (HEXO) delivered earnings and revenue surprises of 20.00% and 58.39%, respectively, for the quarter ended April 2020. Do the numbers hold clues to what lies ahead for the stock?

HEXO (HEXO) Reports Q3 Loss, Tops Revenue Estimates

OTTAWA, June  11, 2020  (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced an initial closing of its previously announced early conversion option (the “Early Conversion Option”) in respect of $29.86 million aggregate principal amount of its outstanding $70 million aggregate principal amount of 8% unsecured convertible debentures maturing December 5, 2022 (the “Debentures”). Under the initial closing, $23.595 million aggregate principal amount of Debentures was converted into ‎29,493,750 units of the Company (the “Conversion Units”) at a price of $0.80 per Conversion Unit.

Hexo Corp. Announces Initial Closing of Early Conversion Option for Debentures

Hexo Corp.'s U.S.-listed shares HEXO, -7.33% HEXO, -6.25% soared 19% in premarket trade Thursday, after the Canadian cannabis company beat revenue estimates for its fiscal third quarter.

Hexo Corp. shares soar premarket after revenue tops estimates

Canopy Growth

Cronos Group

Cannabis stocks in general stumbled in the latter half of last year. Wall Street expects profits, and none of these companies is anywhere near profitability.

Short Sellers Hike Their Bets in Cannabis Stocks

Hexo's (HEXO) fiscal third-quarter results are likely to reflect operational efficiency and strong product portfolio.

Hexo Corp. (HEXO) to Post Q3 Earnings: What's in the Offing?

Aphria

OrganiGram Holdings Inc.

Could this be the next industry to rebound?

Why Aurora Cannabis, HEXO, Cronos Group, and Other Cannabis Stocks Surged Today

A new version of a medical marijuana product, plus positive news on the derivatives front, has boosted investor confidence in the cannabis company.

Why HEXO Shares Burned Almost 6% Brighter on Thursday

HEXO (HEXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate HEXO (HEXO) to Report a Decline in Earnings: What to Look Out for

OTTAWA, June  03, 2020  (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) is proud to launch new 30 gram medical flower format for its popular high-THC strain Tsunami under HEXO medical cannabis.

HEXO launches new Tsunami 30 g flower format exclusively to medical clients

Bull of the Day: Hexo Corp (HEXO)

The Ontario site will produce the drinks for Truss Beverages, Hexo's joint venture with Molson Coors.

Hexo Receives Expanded License to Use Its Main Facility to Produce Cannabis Beverages

HEXO saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.

HEXO in Focus: Stock Moves 9% Higher

OTTAWA, June  01, 2020  (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX:HEXO; NYSE:HEXO) is pleased to announce it has received its Health Canada licence amendment for the sale of dried and fresh cannabis, cannabis extracts, cannabis topicals and edible cannabis products for its cannabis manufacturing and processing facility in Belleville, Ontario. The updated licensing also encompasses the expansion of the licensed area to include the beverage production area dedicated to the Truss/HEXO beverage division.  

HEXO’s Belleville facility receives its sales license

Curaleaf Holdings, Inc.

Marijuana stocks are already getting buying interest ahead of the major event

7 Marijuana Stocks to Watch as the Presidential Election Approaches

OTTAWA, May  21, 2020  (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) today announced the closing of its previously announced underwritten public offering (the “Offering”) for total gross proceeds to the Company of C$57,546,000. The Company sold 63,940,000 units of the Company (the “Units”) at a price of C$0.90 per Unit under the Offering, including 8,340,000 Units sold pursuant to the exercise in full of the underwriters’ over-allotment option.

News for HEXO Corp Stock (HEXO)